Marwan Chami

Marwan Chami is currently a Subject Matter Expert in Digital Pathology at Merck Group. Prior to this role, Marwan worked as a Quality Control and Data Management Consultant at Definiens, a subsidiary of AstraZeneca. Marwan's background includes experience in Neuropathology and Neuroimmunology research, with a focus on brain tumor diagnostics. Marwan has a Dr. rer. nat. degree in Neuroimmunology from Universität des Saarlandes.